baber/WOPTO huggingface dataset:
Patent DE-69621954-D1 (DE)
Inventor: CARRIER W
IPC: G01B5/008
Filed: 1996-01-16
Granted: 2002-07-25
Abstract: A coordinate measuring machine has a single vertical column mounted to a horizontal table for moving in the x-direction, and a carriage mounted on the column for vertical movement in the z-direction. The column is moved with a motor that drives a rack and pinion. The carriage supports a y-rail that moves in the y-direction. A first damper is positioned over the z-rail in the -y direction so that the column is intermediate the damper and the probe. A second damper is positioned at an end of the y-rail near the probe. The dampers reduce both large amplitude transients, as well as steady-state vibrations that are caused by the motor cogging and gearing between the motor and the rack and pinion.
Patent DE-69624823-D1 (DE)
Inventor: TOLSTOGUZOV VLADIMIR BORISOVIC
IPC: C08B37/00
Filed: 1996-11-18
Granted: 2002-12-19
Abstract: A process for concentrating a dilute polysaccharide in an aqueous medium which comprises contacting a first dilute polysaccharide with a second polysaccharide having a greater hydrophilicity than that of the first polysaccharide in an aqueous medium to form two phases, one of which contains the first dilute polysaccharide in a heavier more concentrated gel form and the other contains the second polysaccharide in a lighter more diluted form, and separating the two phases.
Patent DE-69627378-D1 (DE)
Inventor: HODGES MCINDOE
IPC: G01N33/487
Filed: 1996-06-19
Granted: 2003-05-15
Abstract: A method for determining the concentration of reduced (or oxidised) form of a redox species in an electrochemical cell of the kind comprising a working electrode and a counter electrode spaced from the working electrode by a predetermined distance, said method comprising the steps of: (1) applying an electric difference between the electrodes; (2) selecting the potential of the working electrode such that the rate of electro-oxidation of the reduced form (or electro-reduction of the oxidised form) of the species is diffusion controlled, (3) selecting the spacing between the working electrode and the counter electrode so that reaction products from the counter electrode arrive at the working electrode; (4) determining current as a function of time after application of the potential and prior to achievement of a steady state; (5) estimating the magnitude of the steady state current, and (6) obtaining from the change in current with time and magnitude of the steady state current, a value indicative of the diffusion coefficient and/or of the concentration of the reduced form (or the oxidised form) of the species. Also disclosed is an apparatus for determining the concentration of a redox species in an electrochemical cell comprising: an electrochemical cell having a working electrode and a counter (or counter/reference) electrode, means for applying and electric potential difference between said electrodes, means for measuring the change in current with time, and characterised in that the working electrode is spaced from the counter electrode by less than 500µm.
Patent DE-69628731-D1 (DE)
Inventor: TOURNIER HERVE
IPC: A61K47/48
Filed: 1996-10-31
Granted: 2003-07-24
Abstract: Administrable factors or compositions to be directed to specific sites in the body of human and animal patients which comprise a medically and/or diagnostically effective moiety (I) and, coupled thereto by means of a linker (L), a substance (II) having specific affinity for specific sites in the organism. Linker "L" has a structure schematized by the formula: Y(W-Z-R)m, m being 1, 2, or 4 wherein the portion YW is an amphiphile, i.e. a segment comprised of a hydrophobic-lipophilic sequence "Y" and a hydrophilic-lipophobic sequence "W" connected covalently together, Z is a chemical bond or an intermediate connector sequence and R is a reactive function for effecting coupling with selected substances (II).
Patent DE-69631047-D1 (DE)
Inventor: LIN JHY-JHU
IPC: C12N5/02
Filed: 1996-04-26
Granted: 2004-01-22
Abstract: The present invention describes the use of 5-bromoindole-3-acetic acid (5-B-IAA) as an auxin affecting plant cell growth. The invention relates to the use of 5-B-IAA compositions to affect growth in monocotyledonous as well as in dicotyledonous plants. The invention also describes the use of 5-B-IAA in plant growth affecting compositions for the regeneration of both plant tissues and transgenic plant tissues. Further, the invention provides plant growth affecting compositions comprising 5-B-IAA alone or in a mixture comprising one or more additional plant growth regulators, such as cytokinin, etc.
Patent DE-69632969-D1 (DE)
Inventor: MIS JOSEPH DANIEL
IPC: H01L21/288
Filed: 1996-03-18
Granted: 2004-08-26
Abstract: A method for forming solder bumps (42) on a microelectronic device having a substrate (22) and a contact pad (24) on said substrate (22), wherein said contact pad (24) has an exposed surface portion. The method comprises forming a titanium barrier layer (28) on said contact pad (24), wherein said barrier layer (28) covers said exposed surface portion of said contact pad (24) and extends over said substrate; forming an under bump metallurgy layer on said barrier layer (28) opposite said substrate (22); forming a solder bump (42) on said under bump metallurgy layer opposite said exposed surface portion of said contact pad (24) and said barrier layer (28) thereby defining exposed and unexposed surface portions of said under bump metallurgy layer; selectively removing said exposed portion of said under bump metallurgy layer thereby defining an exposed portion of said barrier layer (28) and selectively removing said exposed portion of said barrier layer (28). The step of forming an under bump metallurgy layer comprises the steps of forming a chromium layer (30) on said titanium barrier layer (28) and forming a copper layer (34) on said chromium layer (30) opposite said barrier layer (28). <IMAGE>
Patent DE-69635052-D1 (DE)
Inventor: ODAWARA FUMITOMO
IPC: C12Q1/6804
Filed: 1996-05-24
Granted: 2005-09-15
Abstract: Disclosed is a method for quantitatively determining an antibody, contained in a biological sample, having the ability to inhibit the activity of a reverse transcriptase derived from an HIV, comprising: reacting a hybridization product, immobilized on a solid phase, of a primer consisting essentially of oligodeoxythymine nucleotide and an RNA template consisting essentially of adenine ribopolynucleotide with a reverse transcriptase derived from HIV, to thereby bind the reverse transcriptase to the hybridization product; conducting a synthesis of a DNA complementary to the RNA template from a deoxymononucleotide triphosphate in the presence of the reverse transcriptase activity-inhibiting antibody; and measuring the amount of the synthesized DNA and quantitatively determining the above-mentioned antibody, based on the measured amount of the synthesized DNA. The method of the present invention can be performed with ease and with high reproducibility in classifying and quantitatively determining the antibodies against the epitopes of a viral reverse transcriptase. By the method of the present invention, not only the virus having mutated during a latent period thereof, and the properties which the virus exhibits as a result of the mutation, but also a virus having acquired drug resistance as a result of the administration of the drugs to the host, can be studied by quantitatively determining the antibodies. Further, it has also become possible to accurately and promptly determine the changes in the infected host, such as the change in the ability to produce antibodies, which occur in accordance with the progression of illness.
Patent DE-69703619-D1 (DE)
Inventor: TJOENG S
IPC: C07J41/00
Filed: 1997-04-28
Granted: 2001-01-04
Abstract: The present invention relates to a pharmaceutical composition or preparation which comprises hydroxyl containing steroidal hormones and organic nitrite/nitrate or other nitric oxide donating agents.
Patent DE-69710741-D1 (DE)
Inventor: RANE F
IPC: A61K31/4427
Filed: 1997-09-11
Granted: 2002-04-04
Abstract: Compounds of formula (1.0), their use as farnesyl transferase protein inhibitors and pharmaceutical compositions containing them are disclosed, especially compounds of formula (1.5A) wherein R<1>, R<2> and R<3> are halo, A and B are each H2, and R is as defined in the specification.
Patent DE-69718477-D1 (DE)
Inventor: SINGH RANBIR
IPC: H01L29/417
Filed: 1997-05-29
Granted: 2003-02-20
Abstract: A silicon carbide (SiC) metal-insulator semiconductor field effect transistor having a u-shaped gate trench and an n-type SiC drift layer is provided. A p-type region is formed in the SiC drift layer and extends below the bottom of the u-shaped gate trench to prevent field crowding at the corner of the gate trench. A unit cell of a metal-insulator semiconductor transistor is provided having a bulk single crystal SiC substrate of n-type conductivity SiC, a first epitaxial layer of n-type SiC and a second epitaxial layer of p-type SiC. First and second trenches extend downward through the second epitaxial layer and into the first epitaxial layer with a region of n-type SiC between the trenches. An insulator layer is formed in the first trench with the upper surface of the insulator on the bottom of the trench below the second epitaxial layer. A region of p-type SiC is formed in the first epitaxial layer below the second trench. Gate and source contacts are formed in the first and second trenches respectively and a drain contact is formed on the substrate.
Patent DE-69724630-D1 (DE)
Inventor: CHRIST DONALD
IPC: C07D213/75
Filed: 1997-10-01
Granted: 2003-10-09
Abstract: The present invention relates to benzoxazinones of formula I, <CHEM> or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.
Patent DE-69727146-D1 (DE)
Inventor: O'BRIEN L
IPC: A61K31/4166
Filed: 1997-09-10
Granted: 2004-02-12
Abstract: A fluid which comprises an olefin-terminated polyester an unmodified polyester and a polymerized  alpha -olefin is provided which facilitates the separation of blood into light and heavy phases via centrifugation in a blood collection vessel. The fluid is useful as a component of a partitioning composition formulated to have appropriate specific gravity to be positioned intermediate the light and heavy blood phases during centrifugation. A partitioning composition including a fluid of the invention provides a particular advantage in blood collection vessels used in therapeutic drug monitoring, due to the relatively low affinity between the fluid component of the composition and commonly monitored classes of drugs.
Patent DE-69727242-D1 (DE)
Inventor: BROWN ROBERT
IPC: A61K9/70
Filed: 1997-11-13
Granted: 2004-02-19
Abstract: A method of coating a pharmaceutical substrate includes the steps of applying an active coating material to a surface of the substrate to form an active coating layer and applying a cover coating material onto the active coating layer to form a cover coating layer. The active coating layer is substantially completely covered by the cover coating layer.
Patent DE-69729975-D1 (DE)
Inventor: MOMOSE TSUTOMU
IPC: G06K7/08
Filed: 1997-05-22
Granted: 2004-09-02
Abstract: Disclosed is a device for processing media to check the validity of checks and other negotiable instruments and print as necessary on said media. The device comprises in sequence along a transport path (9) from an insertion opening (6) a transportation mechanism (3), a printing mechanism (4) and a reading mechanism (5). When the medium (8) is transported by the transportation mechanism (3) along the transport path (9) to a predetermined position, the check is positioned between a presser roller (51) and a sensor (52) of the reading mechanism (5). The presser roller (51) then presses the check (8) against the sensor (52) while the transportation mechanism (3) pulls the check and information recorded on the check is read. This operation straightens wrinkles and removes slack from check (8) to reduce reading errors. Based on the read information, a printing process is then executed by the printing mechanism (4) and the check is ejected from the insertion opening (6). Task efficiency is therefore good, and the occupied space can be minimized. <IMAGE>
Patent DE-69732501-D1 (DE)
Inventor: ALMQUIST VIDAR
IPC: C08F2/00
Filed: 1997-03-05
Granted: 2005-03-17
Abstract: A method of catalyst transitions in olefin polymerisations. A method for transitioning between two different catalysts in olefin polymerisations, a first catalyst and a second catalyst, comprising the steps of:   a) discontinuing the feed of the first catalyst into the polymerisation reactor, and then b) introducing the second catalyst into the reactor, characterised in that the transitioning is performed between a chromium-based catalyst and a metallocene catalyst in the absence of any agent which deactivates or kills the catalyst.
Patent DE-69733369-D1 (DE)
Inventor: OR YAT SUN
IPC: A61K31/70
Filed: 1997-09-02
Granted: 2005-06-30
Abstract: 6-Substituted ketolides of e.g. formula (II) or (III), and their salts, esters and prodrugs are new: Y + Z = X; X = OH, =NOR1 or =NOC(R5)(R6)OR1; or one of Y and Z = H; and the other = H, OH, protected OH or NR7R8; R1 = 1-12C alkyl (optionally substituted), 3-12C cycloalkyl or SiR2R3R4; R2-R4 = 1-12C alkyl or aryl; R5, R6 = H or 1-12C alkyl (optionally substituted), or R5 + R6 = 3-12C cycloalkyl; R7, R8 = H or 1-6C alkyl; or NR7R8 = 3-7 membered ring which, when the ring is 5-7 membered may optionally contain O, NH, N(1-6C alkyl), N(aryl), N(aryl-1-6C alkyl), N (substituted aryl-1-6C alkyl), N(heteroaryl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S or S(O)n; n = 1 or 2; Ra = H or OH; Rc = H or hydroxy protecting group; R9 = 1-6C alkyl (optionally substituted), 3-7C cycloalkyl or optionally substituted aryl or heteroaryl; M = CONH, NHCO, NH, N=, NMe, NHCOO, NHCONH, OCONHY, OCOO, O, S(O)n, COO, OCO or CO; R = methyl (substituted by CN, F, CO2R10, S(O)nR10, NHCOR10, NHCONR11R12, aryl, substituted aryl, heteroaryl or substituted heteroaryl); 2-10C alkyl (optionally substituted), 3C alkenyl (substituted by halo, CHO, CO2R10, COR9, CONR11R12, CN, optionally substituted aryl or heteroaryl, 3-7C cycloalkyl or 1-12C alkyl substituted by heteroaryl); 4-10C alkenyl (optionally substituted), or 3-10C alkynyl optionally substituted); R10 = 1-3C alkyl (optionally aryl substituted), or heteroaryl substituted 1-3C alkyl; R11, R12 = H or 1-3C alkyl (optionally substituted); A, B, D, E = H, 1-6C alkyl (optionally substituted by optionally substituted), 3-7C cycloalkyl, optionally substituted aryl or heteroaryl, heterocycloalkyl or 1-6C alkyl substituted by MR9; provided that \- 2 of A, B, D and E = H; or any one pair of substituents, consisting of AB, AD, AE, BD, BE or DE taken with the atoms to which they are attached, form a 3- to 7-membered ring optionally containing O, NH, N(1-6C alkyl), N(aryl-1-6C alkyl), N(substituted aryl-1-6C alkyl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S, S(O)n, CONH, CONR12, NHCO, NR12CO or C(=NH)NH.
Patent DE-69803830-D1 (DE)
Inventor: HEKSTRA ANDRIES PIETER
IPC: G06T9/00
Filed: 1998-03-02
Granted: 2002-03-21
Abstract: A method of and an arrangement for obtaining quality indicators for an objective assessment of a degraded or output video signal (11) with respect to a reference or input video signal (10). The strength of edges or signal transitions (12; 13) in both the input and the output video signals (10; 11) are calculated (14) providing input and output edge signals (15; 16). By processing (19; 21, 22) the edge signals (15; 16) introduced edges (23) and omitted edges (24) in the output edge signal (16) are established. For each of the luminance and chrominance signals of a colour video signal first and second quality indicators are obtained from normalized values of the introduced edges (23) and the omitted edges (24), relative to the output edge signal (23) and the input edge signal (24) normalized by first and second normalization factors, respectively. By using smeared Sobel filtering, correlation of calculated MOS and observed MOS by human test persons reaches a value of above 0.9. <IMAGE>
Patent DE-69804510-D1 (DE)
Inventor: AMAUDRIC DU CHAFFAUT BENOIT
IPC: F16L11/16
Filed: 1998-12-11
Granted: 2002-05-02
Abstract: The invention concerns a method for the continuous production of a flexible tube body from two stapled wires (9, 10) individually bent in bending means (7, 8), three stitches, unsupported by a mandrel, and such that wires (9, 10) remain constantly in contact so as to optimize their resistance to external pressure. Bending means (7, 8) can be arranged with respect to each other without affecting the bending adjustment. The method consists in stapling the two spirals by elastically deforming the turns so that one crosses the other to cause the wires to overlap partially. The invention also concerns an equipment for producing a flexible tube body.
Patent DE-69804624-D1 (DE)
Inventor: MOROZOWICH WALTER
IPC: A61K9/48
Filed: 1998-07-27
Granted: 2002-05-08
Abstract: The present invention provides a novel pharmaceutical composition based on the use of a particular oil phase which comprises a lipophilic, pharmaceutically active agent, a mixture of diglyceride and monoglyceride in a ratio of from about 9:1 to about 6:4 by weight (diglyceride:monoglyceride) wherein the diglyceride and monoglyceride are mono- or di- unsaturated fatty acid esters of glycerol having sixteen to twenty-two carbon chain length, one or more pharmaceutically acceptable solvents, and one or more pharmaceutically acceptable surfactants. The composition is in a form of self-emulsifying formulation which provides high concentration and high oral bioavailability for lipophilic compounds.
Patent DE-69824869-D1 (DE)
Inventor: JOHNSTONE PETER
IPC: A01F25/13
Filed: 1998-05-01
Granted: 2004-08-05
Abstract: The present specification discloses a plastics material film (1) that is stretched beyond its yield point to about 100% to 400% elongation and thereafter only partially relaxed to release part of the elastic deformation component in the film to retain between about 20% and 80% of the elastic deformation in the film (1), the film thereafter being stored in this partially relaxed state whereby, when it is used, the retained elastic deformation capability is useable for the intended purpose of the film, for example, wrapping a load.
Patent DE-69824936-D1 (DE)
Inventor: BLUE EMILY KELLER
IPC: A23L27/00
Filed: 1998-10-30
Granted: 2004-08-12
Abstract: The present invention relates to modified starches which are prepared by enzymatic hydrolysis of a starch molecule using glucoamylase after the preparation of a starch derivative containing a hydrophobic group or both a hydrophobic and a hydrophilic group, particularly octenyl succinic anhydride starch hydrolyzed by glucoamylase. Such modified starches are useful as emulsifying and/or encapsulating agents, particularly in systems where high load and retention of the active ingredient, low surface oil exposure, and excellent oxidation resistance is desired. The encapsulating agents are useful in a variety of applications including a tablet in which the starch allows for good compressibility and hardness.
Patent DE-69827631-D1 (DE)
Title: Infusionsdüse
Inventor: MAZZEI L
IPC: B01F5/06
Filed: 1998-07-07
Granted: 2004-12-23
Abstract: A stream preparation nozzle which establishes dynamic properties in regions of an already mixed stream of treatment water that comprises water and a treatment substance. The nozzle discharges directly into a body of untreated water. The dynamic properties of the stream created by this nozzle improve the infusion of the treatment water and its treatment substances into the water in the body of water.
Patent DE-69830496-D1 (DE)
Inventor: ANDERSSON S
IPC: A61K9/19
Filed: 1998-08-07
Granted: 2005-07-14
Abstract: An antifungal composition suitable for parenteral administration to a mammal includes an amount of pimaricin or an antifungal derivative thereof that is effective to inhibit the growth of a fungal infection in a mammal; a pharmaceutically acceptable dipolar aprotic solvent; and a pharmaceutically acceptable aqueous secondary solvent. The composition can be used in methods of preventing or treating a systemic fungal infection in a mammal. The composition can be prepared by dissolving pimaricin or an antifungal derivative thereof in the pharmaceutically acceptable dipolar aprotic solvent; adding to the solution a pharmaceutically acceptable aqueous secondary solvent; and in a preferred method, by subsequently lypohilizing the composition, whereby a dry, shelf-stable composition is produced. This dry composition can be reconstituted into an aqueous solution suitable for parenteral administration.
Patent DE-69837253-D1 (DE)
Inventor: SALONAHO OSCAR
IPC: H04L1/18
Filed: 1998-09-11
Granted: 2007-04-19
Abstract: A radio connection is adapted to an environment changing over the connection in a cellular radio system where the radio traffic between the base station and the mobile stations is arranged on a multiple access principle, according to a given frame structure (402). For a given radio connection between the transmitting device and the receiving device, there is reserved a given data transmission capacity in said frame structure. The receiving device measures the connection quality (103) during the connection, and on the basis of the measured connection quality, the size of the data transmission capacity (104, 110) reserved for said connection in said frame structure is changed. <IMAGE>
Patent DE-69901328-D1 (DE)
Inventor: BOIS HENRI GEORGES
IPC: B65D33/02
Filed: 1999-06-17
Granted: 2002-05-29
Abstract: A bag including two generally parallel sheets forming the main walls of the bag, complementary closure strips fixed to respective ones of the sheets, and a cursor for actuating the strips for closing and opening purposes. The bag further includes, parallel to the closure strips, between the sheets, and level with the mouth of the bag, additional structure in relief disposed on the insides of the closure strips, designed to provide sealing by forming a barrier between the sheets in the closed position of the bag, the additional structure in relief being placed facing the flanks of the cursor to be urged towards their sealing position by the cursor when the cursor is moved towards the sealing position.
Patent DE-69904652-D1 (DE)
Inventor: INABA TAKASHI
IPC: C07D317/28
Filed: 1999-01-15
Granted: 2003-02-06
Abstract: A method for producing an optically active amino alcohol compound of the formula Ä3Ü, an enantiomer thereof or a salt thereof, comprising reacting a mesoepoxide compound of the formula Ä1Ü with a compound of the formula Ä2Ü in the presence of a mixed catalyst comprising a Lewis acid and a proton donor: <CHEM> wherein R<1>, R<2> and R<3> are each H, an optionally substituted lower alkyl, and the like, or R<1> and R<1> or R<2> and R<3> may form an optionally substituted ring; and R<4> and R<5> are each H, an optionally substituted lower alkyl, and the like, or R<4> and R<5> may form an optionally substituted ring together with the adjacent N, or an imide group or azide group together with the adjacent N, and R<6> is H or a silyl group. The present invention enables stereoselective production of a desired intermediate compound, which is an HIV protease inhibitor, extremely efficiently as compared to conventional methods. The method of the present invention is a very useful method which can be used not only for the production of said intermediate compound but also for the production of various other compounds.